These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 38376441)
1. Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma. Zhao C; Liu L; He Q; Li Y; Feng J; Chen Y; Li Y; Xu X; Zhu S; Ye Y; Wen Y; Zeng Z; Zhou D; Jin F Aging (Albany NY); 2024 Feb; 16(4):3837-3855. PubMed ID: 38376441 [TBL] [Abstract][Full Text] [Related]
2. The Clinical Significance of Dickkopf Wnt Signaling Pathway Inhibitor Gene Family in Head and Neck Squamous Cell Carcinoma. Hu Y; Liu M; Xu S; Li S; Yang M; Su T; Yuan Z; Peng H Med Sci Monit; 2020 Nov; 26():e927368. PubMed ID: 33281184 [TBL] [Abstract][Full Text] [Related]
3. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
4. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
5. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682 [TBL] [Abstract][Full Text] [Related]
6. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648 [TBL] [Abstract][Full Text] [Related]
7. AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma. Mao L; Pan Z; Chen W; Hu W; Chen X; Dai H BMC Med Genomics; 2023 Mar; 16(1):67. PubMed ID: 36998036 [TBL] [Abstract][Full Text] [Related]
8. High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status. Zou M; Wu H; Zhou M; Xiao F; Abudushalamu G; Yao Y; Zhao F; Gao W; Yan X; Fan X; Wu G Cell Immunol; 2022 Feb; 372():104472. PubMed ID: 35093731 [TBL] [Abstract][Full Text] [Related]
9. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma. Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393 [TBL] [Abstract][Full Text] [Related]
10. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment. He Y; Xiang J; Li Y; Huang W; Gu F; Wang Y; Chen R Cancer Med; 2023 Jun; 12(11):12622-12638. PubMed ID: 37076985 [TBL] [Abstract][Full Text] [Related]
11. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma. Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786 [TBL] [Abstract][Full Text] [Related]
13. Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma. Xu X; Li R; Zhang L; Zhu G; Ren D; Wu L; Gong X Diagn Pathol; 2021 Nov; 16(1):110. PubMed ID: 34823553 [TBL] [Abstract][Full Text] [Related]
14. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma. Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL Front Immunol; 2022; 13():969034. PubMed ID: 36466881 [TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma. Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115 [TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma. Shi Y; Gong HL; Zhou L; Tian J; Wang Y Acta Otolaryngol; 2014 Jul; 134(7):753-9. PubMed ID: 24834937 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma. Zhu X; Heng Y; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L Hum Cell; 2024 May; 37(3):714-728. PubMed ID: 38358636 [TBL] [Abstract][Full Text] [Related]
18. Dickkopf-1 drives perineural invasion via PI3K-AKT signaling pathway in head and neck squamous cancer. Wang J; Li Q; Liang F; Du X; Song P; Wu T; Chen R; Lin X; Liu Q; Hu H; Han P; Huang X MedComm (2020); 2024 Apr; 5(4):e518. PubMed ID: 38525111 [TBL] [Abstract][Full Text] [Related]
19. Elevated Gao H; Li L; Xiao M; Guo Y; Shen Y; Cheng L; Tang M Cancer Manag Res; 2018; 10():5083-5089. PubMed ID: 30464608 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma. Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]